HomeGALT • NASDAQ
add
Galectin Therapeutics Inc. Common Stock
Previous close
$3.23
Day range
$3.06 - $3.28
Year range
$1.28 - $4.27
Market cap
195.62M USD
Avg Volume
233.40K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
.DJI
0.49%
4.50%
0.49%
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 9.65M | -6.71% |
Net income | -11.49M | 0.33% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | — | — |
Total assets | — | — |
Total liabilities | — | — |
Total equity | — | — |
Shares outstanding | — | — |
Price to book | — | — |
Return on assets | — | — |
Return on capital | -208.54% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -11.49M | 0.33% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2000
Headquarters
Website
Employees
14